These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31545995)

  • 1. Selectivity of (±)-citalopram at nicotinic acetylcholine receptors and different inhibitory mechanisms between habenular α3β4* and α9α10 subtypes.
    Arias HR; Jin XT; Gallino S; Peng C; Feuerbach D; García-Colunga J; Elgoyhen AB; Drenan RM; Ortells MO
    Neurochem Int; 2019 Dec; 131():104552. PubMed ID: 31545995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selectivity of coronaridine congeners at nicotinic acetylcholine receptors and inhibitory activity on mouse medial habenula.
    Arias HR; Jin X; Feuerbach D; Drenan RM
    Int J Biochem Cell Biol; 2017 Nov; 92():202-209. PubMed ID: 29042244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tricyclic antidepressants inhibit hippocampal α7* and α9α10 nicotinic acetylcholine receptors by different mechanisms.
    Arias HR; Vázquez-Gómez E; Hernández-Abrego A; Gallino S; Feuerbach D; Ortells MO; Elgoyhen AB; García-Colunga J
    Int J Biochem Cell Biol; 2018 Jul; 100():1-10. PubMed ID: 29704625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of selective serotonin reuptake inhibitors with neuronal nicotinic acetylcholine receptors.
    Arias HR; Feuerbach D; Targowska-Duda KM; Russell M; Jozwiak K
    Biochemistry; 2010 Jul; 49(27):5734-42. PubMed ID: 20527991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different interaction between tricyclic antidepressants and mecamylamine with the human alpha3beta4 nicotinic acetylcholine receptor ion channel.
    Arias HR; Targowska-Duda KM; Feuerbach D; Sullivan CJ; Maciejewski R; Jozwiak K
    Neurochem Int; 2010 Mar; 56(4):642-9. PubMed ID: 20117161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drimane Sesquiterpenoids Noncompetitively Inhibit Human α4β2 Nicotinic Acetylcholine Receptors with Higher Potency Compared to Human α3β4 and α7 Subtypes.
    Arias HR; Feuerbach D; Schmidt B; Heydenreich M; Paz C; Ortells MO
    J Nat Prod; 2018 Apr; 81(4):811-817. PubMed ID: 29634269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronaridine congeners inhibit human α3β4 nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites.
    Arias HR; Targowska-Duda KM; Feuerbach D; Jozwiak K
    Int J Biochem Cell Biol; 2015 Aug; 65():81-90. PubMed ID: 26022277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel positive allosteric modulators of the human α7 nicotinic acetylcholine receptor.
    Arias HR; Gu RX; Feuerbach D; Guo BB; Ye Y; Wei DQ
    Biochemistry; 2011 Jun; 50(23):5263-78. PubMed ID: 21510634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional and structural interaction of (-)-reboxetine with the human α4β2 nicotinic acetylcholine receptor.
    Arias HR; Fedorov NB; Benson LC; Lippiello PM; Gatto GJ; Feuerbach D; Ortells MO
    J Pharmacol Exp Ther; 2013 Jan; 344(1):113-23. PubMed ID: 23010362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alkaloids Purified from
    Arias HR; Ortells MO; Feuerbach D; Burgos V; Paz C
    J Nat Prod; 2019 Jul; 82(7):1953-1960. PubMed ID: 31276409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (-)-Reboxetine inhibits muscle nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites.
    Arias HR; Ortells MO; Feuerbach D
    Neurochem Int; 2013 Nov; 63(5):423-31. PubMed ID: 23917086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological and molecular studies on the interaction of varenicline with different nicotinic acetylcholine receptor subtypes. Potential mechanism underlying partial agonism at human α4β2 and α3β4 subtypes.
    Arias HR; Feuerbach D; Targowska-Duda K; Kaczor AA; Poso A; Jozwiak K
    Biochim Biophys Acta; 2015 Feb; 1848(2):731-41. PubMed ID: 25475645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bupropion and its photoreactive analog (±)-SADU-3-72 interact with luminal and non-luminal sites at human α4β2 nicotinic acetylcholine receptors.
    Arias HR; Feuerbach D; Ortells MO
    Neurochem Int; 2016 Nov; 100():67-77. PubMed ID: 27612850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel 2-(substituted benzyl)quinuclidines inhibit human α7 and α4β2 nicotinic receptors by different mechanisms.
    Arias HR; López JJ; Feuerbach D; Fierro A; Ortells MO; Pérez EG
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2420-30. PubMed ID: 23954208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tricyclic antidepressants and mecamylamine bind to different sites in the human alpha4beta2 nicotinic receptor ion channel.
    Arias HR; Rosenberg A; Targowska-Duda KM; Feuerbach D; Jozwiak K; Moaddel R; Wainer IW
    Int J Biochem Cell Biol; 2010 Jun; 42(6):1007-18. PubMed ID: 20223294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tabernanthalog and ibogainalog inhibit the α7 and α9α10 nicotinic acetylcholine receptors via different mechanisms and with higher potency than the GABA
    Tae HS; Ortells MO; Yousuf A; Xu SQ; Akk G; Adams DJ; Arias HR
    Biochem Pharmacol; 2024 May; 223():116183. PubMed ID: 38580167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of nicotinic acetylcholine receptors by inhibitors of monoamine uptake.
    López-Valdés HE; García-Colunga J
    Mol Psychiatry; 2001 Sep; 6(5):511-9. PubMed ID: 11526465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional and structural interaction of (-)-lobeline with human α4β2 and α4β4 nicotinic acetylcholine receptor subtypes.
    Arias HR; Feuerbach D; Ortells M
    Int J Biochem Cell Biol; 2015 Jul; 64():15-24. PubMed ID: 25794424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Determinants of α3β4 Nicotinic Acetylcholine Receptors Inhibition by Triterpenoids.
    Eom S; Kim YS; Lee SB; Noh S; Yeom HD; Bae H; Lee JH
    Biol Pharm Bull; 2018; 41(1):65-72. PubMed ID: 29311484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DM506 (3-Methyl-1,2,3,4,5,6-hexahydroazepino[4,5-
    Tae HS; Ortells MO; Tekarli BJ; Manetti D; Romanelli MN; McIntosh JM; Adams DJ; Arias HR
    ACS Chem Neurosci; 2023 Jul; 14(14):2537-2547. PubMed ID: 37386821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.